カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のトラスツズマブバイオシミラー市場予測2023-2029：アジュバント乳がん、転移性乳がん、転移性胃がん、その他

【英語タイトル】Trastuzumab Biosimilar Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8720）・商品コード：MMG23LY8720
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：71
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のトラスツズマブバイオシミラー市場規模と予測を収録しています。・世界のトラスツズマブバイオシミラー市場：売上、2018年-2023年、2024年-2029年
・世界のトラスツズマブバイオシミラー市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のトラスツズマブバイオシミラー市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アジュバント乳がん」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

トラスツズマブバイオシミラーのグローバル主要企業は、Amgen Inc.、 Pfizer Inc、 Samsung Bioepis、 Merck & Co.、 Biocon Limited、 Teva Pharmaceutical、 Genentech、 Mundipharma、 Celltrion、 Henliusなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、トラスツズマブバイオシミラーのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のトラスツズマブバイオシミラー市場：タイプ別、2018年-2023年、2024年-2029年
世界のトラスツズマブバイオシミラー市場：タイプ別市場シェア、2022年
・アジュバント乳がん、転移性乳がん、転移性胃がん、その他

世界のトラスツズマブバイオシミラー市場：用途別、2018年-2023年、2024年-2029年
世界のトラスツズマブバイオシミラー市場：用途別市場シェア、2022年
・病院薬局、オンライン薬局

世界のトラスツズマブバイオシミラー市場：地域・国別、2018年-2023年、2024年-2029年
世界のトラスツズマブバイオシミラー市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるトラスツズマブバイオシミラーのグローバル売上、2018年-2023年
・主要企業におけるトラスツズマブバイオシミラーのグローバル売上シェア、2022年
・主要企業におけるトラスツズマブバイオシミラーのグローバル販売量、2018年-2023年
・主要企業におけるトラスツズマブバイオシミラーのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Amgen Inc.、 Pfizer Inc、 Samsung Bioepis、 Merck & Co.、 Biocon Limited、 Teva Pharmaceutical、 Genentech、 Mundipharma、 Celltrion、 Henlius

*************************************************************

・調査・分析レポートの概要
トラスツズマブバイオシミラー市場の定義
市場セグメント
世界のトラスツズマブバイオシミラー市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のトラスツズマブバイオシミラー市場規模
世界のトラスツズマブバイオシミラー市場規模：2022年 VS 2029年
世界のトラスツズマブバイオシミラー市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのトラスツズマブバイオシミラーの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のトラスツズマブバイオシミラー製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：アジュバント乳がん、転移性乳がん、転移性胃がん、その他
トラスツズマブバイオシミラーのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、オンライン薬局
トラスツズマブバイオシミラーの用途別グローバル売上・予測

・地域別市場分析
地域別トラスツズマブバイオシミラー市場規模 2022年と2029年
地域別トラスツズマブバイオシミラー売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen Inc.、 Pfizer Inc、 Samsung Bioepis、 Merck & Co.、 Biocon Limited、 Teva Pharmaceutical、 Genentech、 Mundipharma、 Celltrion、 Henlius
...

Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
This report aims to provide a comprehensive presentation of the global market for Trastuzumab Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab Biosimilar. This report contains market size and forecasts of Trastuzumab Biosimilar in global, including the following market information:
Global Trastuzumab Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Trastuzumab Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Trastuzumab Biosimilar companies in 2022 (%)
The global Trastuzumab Biosimilar market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Trastuzumab Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trastuzumab Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, by Type, 2022 (%)
Adjuvant Breast Cancer
Metastatic Breast Cancer
Metastatic Gastric Cancer
Others
Global Trastuzumab Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Online Pharmacy
Global Trastuzumab Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trastuzumab Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Trastuzumab Biosimilar revenues share in global market, 2022 (%)
Key companies Trastuzumab Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Trastuzumab Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
Pfizer Inc
Samsung Bioepis
Merck & Co.
Biocon Limited
Teva Pharmaceutical
Genentech
Mundipharma
Celltrion
Henlius
Outline of Major Chapters:
Chapter 1: Introduces the definition of Trastuzumab Biosimilar, market overview.
Chapter 2: Global Trastuzumab Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Trastuzumab Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Trastuzumab Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Trastuzumab Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Trastuzumab Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Trastuzumab Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Trastuzumab Biosimilar Overall Market Size
2.1 Global Trastuzumab Biosimilar Market Size: 2022 VS 2029
2.2 Global Trastuzumab Biosimilar Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Trastuzumab Biosimilar Sales: 2018-2029
3 Company Landscape
3.1 Top Trastuzumab Biosimilar Players in Global Market
3.2 Top Global Trastuzumab Biosimilar Companies Ranked by Revenue
3.3 Global Trastuzumab Biosimilar Revenue by Companies
3.4 Global Trastuzumab Biosimilar Sales by Companies
3.5 Global Trastuzumab Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Trastuzumab Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Trastuzumab Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Trastuzumab Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Trastuzumab Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Trastuzumab Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Trastuzumab Biosimilar Market Size Markets, 2022 & 2029
4.1.2 Adjuvant Breast Cancer
4.1.3 Metastatic Breast Cancer
4.1.4 Metastatic Gastric Cancer
4.1.5 Others
4.2 By Type – Global Trastuzumab Biosimilar Revenue & Forecasts
4.2.1 By Type – Global Trastuzumab Biosimilar Revenue, 2018-2023
4.2.2 By Type – Global Trastuzumab Biosimilar Revenue, 2024-2029
4.2.3 By Type – Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
4.3 By Type – Global Trastuzumab Biosimilar Sales & Forecasts
4.3.1 By Type – Global Trastuzumab Biosimilar Sales, 2018-2023
4.3.2 By Type – Global Trastuzumab Biosimilar Sales, 2024-2029
4.3.3 By Type – Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
4.4 By Type – Global Trastuzumab Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Trastuzumab Biosimilar Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.2 By Application – Global Trastuzumab Biosimilar Revenue & Forecasts
5.2.1 By Application – Global Trastuzumab Biosimilar Revenue, 2018-2023
5.2.2 By Application – Global Trastuzumab Biosimilar Revenue, 2024-2029
5.2.3 By Application – Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
5.3 By Application – Global Trastuzumab Biosimilar Sales & Forecasts
5.3.1 By Application – Global Trastuzumab Biosimilar Sales, 2018-2023
5.3.2 By Application – Global Trastuzumab Biosimilar Sales, 2024-2029
5.3.3 By Application – Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
5.4 By Application – Global Trastuzumab Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Trastuzumab Biosimilar Market Size, 2022 & 2029
6.2 By Region – Global Trastuzumab Biosimilar Revenue & Forecasts
6.2.1 By Region – Global Trastuzumab Biosimilar Revenue, 2018-2023
6.2.2 By Region – Global Trastuzumab Biosimilar Revenue, 2024-2029
6.2.3 By Region – Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
6.3 By Region – Global Trastuzumab Biosimilar Sales & Forecasts
6.3.1 By Region – Global Trastuzumab Biosimilar Sales, 2018-2023
6.3.2 By Region – Global Trastuzumab Biosimilar Sales, 2024-2029
6.3.3 By Region – Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Trastuzumab Biosimilar Revenue, 2018-2029
6.4.2 By Country – North America Trastuzumab Biosimilar Sales, 2018-2029
6.4.3 US Trastuzumab Biosimilar Market Size, 2018-2029
6.4.4 Canada Trastuzumab Biosimilar Market Size, 2018-2029
6.4.5 Mexico Trastuzumab Biosimilar Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Trastuzumab Biosimilar Revenue, 2018-2029
6.5.2 By Country – Europe Trastuzumab Biosimilar Sales, 2018-2029
6.5.3 Germany Trastuzumab Biosimilar Market Size, 2018-2029
6.5.4 France Trastuzumab Biosimilar Market Size, 2018-2029
6.5.5 U.K. Trastuzumab Biosimilar Market Size, 2018-2029
6.5.6 Italy Trastuzumab Biosimilar Market Size, 2018-2029
6.5.7 Russia Trastuzumab Biosimilar Market Size, 2018-2029
6.5.8 Nordic Countries Trastuzumab Biosimilar Market Size, 2018-2029
6.5.9 Benelux Trastuzumab Biosimilar Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Trastuzumab Biosimilar Revenue, 2018-2029
6.6.2 By Region – Asia Trastuzumab Biosimilar Sales, 2018-2029
6.6.3 China Trastuzumab Biosimilar Market Size, 2018-2029
6.6.4 Japan Trastuzumab Biosimilar Market Size, 2018-2029
6.6.5 South Korea Trastuzumab Biosimilar Market Size, 2018-2029
6.6.6 Southeast Asia Trastuzumab Biosimilar Market Size, 2018-2029
6.6.7 India Trastuzumab Biosimilar Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Trastuzumab Biosimilar Revenue, 2018-2029
6.7.2 By Country – South America Trastuzumab Biosimilar Sales, 2018-2029
6.7.3 Brazil Trastuzumab Biosimilar Market Size, 2018-2029
6.7.4 Argentina Trastuzumab Biosimilar Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Trastuzumab Biosimilar Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Trastuzumab Biosimilar Sales, 2018-2029
6.8.3 Turkey Trastuzumab Biosimilar Market Size, 2018-2029
6.8.4 Israel Trastuzumab Biosimilar Market Size, 2018-2029
6.8.5 Saudi Arabia Trastuzumab Biosimilar Market Size, 2018-2029
6.8.6 UAE Trastuzumab Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Trastuzumab Biosimilar Major Product Offerings
7.1.4 Amgen Inc. Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 Pfizer Inc
7.2.1 Pfizer Inc Company Summary
7.2.2 Pfizer Inc Business Overview
7.2.3 Pfizer Inc Trastuzumab Biosimilar Major Product Offerings
7.2.4 Pfizer Inc Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Inc Key News & Latest Developments
7.3 Samsung Bioepis
7.3.1 Samsung Bioepis Company Summary
7.3.2 Samsung Bioepis Business Overview
7.3.3 Samsung Bioepis Trastuzumab Biosimilar Major Product Offerings
7.3.4 Samsung Bioepis Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.3.5 Samsung Bioepis Key News & Latest Developments
7.4 Merck & Co.
7.4.1 Merck & Co. Company Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. Trastuzumab Biosimilar Major Product Offerings
7.4.4 Merck & Co. Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co. Key News & Latest Developments
7.5 Biocon Limited
7.5.1 Biocon Limited Company Summary
7.5.2 Biocon Limited Business Overview
7.5.3 Biocon Limited Trastuzumab Biosimilar Major Product Offerings
7.5.4 Biocon Limited Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.5.5 Biocon Limited Key News & Latest Developments
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Company Summary
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Major Product Offerings
7.6.4 Teva Pharmaceutical Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.6.5 Teva Pharmaceutical Key News & Latest Developments
7.7 Genentech
7.7.1 Genentech Company Summary
7.7.2 Genentech Business Overview
7.7.3 Genentech Trastuzumab Biosimilar Major Product Offerings
7.7.4 Genentech Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.7.5 Genentech Key News & Latest Developments
7.8 Mundipharma
7.8.1 Mundipharma Company Summary
7.8.2 Mundipharma Business Overview
7.8.3 Mundipharma Trastuzumab Biosimilar Major Product Offerings
7.8.4 Mundipharma Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.8.5 Mundipharma Key News & Latest Developments
7.9 Celltrion
7.9.1 Celltrion Company Summary
7.9.2 Celltrion Business Overview
7.9.3 Celltrion Trastuzumab Biosimilar Major Product Offerings
7.9.4 Celltrion Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.9.5 Celltrion Key News & Latest Developments
7.10 Henlius
7.10.1 Henlius Company Summary
7.10.2 Henlius Business Overview
7.10.3 Henlius Trastuzumab Biosimilar Major Product Offerings
7.10.4 Henlius Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.10.5 Henlius Key News & Latest Developments
8 Global Trastuzumab Biosimilar Production Capacity, Analysis
8.1 Global Trastuzumab Biosimilar Production Capacity, 2018-2029
8.2 Trastuzumab Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Trastuzumab Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Trastuzumab Biosimilar Supply Chain Analysis
10.1 Trastuzumab Biosimilar Industry Value Chain
10.2 Trastuzumab Biosimilar Upstream Market
10.3 Trastuzumab Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Trastuzumab Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Trastuzumab Biosimilar in Global Market
Table 2. Top Trastuzumab Biosimilar Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Trastuzumab Biosimilar Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Trastuzumab Biosimilar Revenue Share by Companies, 2018-2023
Table 5. Global Trastuzumab Biosimilar Sales by Companies, (K Units), 2018-2023
Table 6. Global Trastuzumab Biosimilar Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Trastuzumab Biosimilar Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Trastuzumab Biosimilar Product Type
Table 9. List of Global Tier 1 Trastuzumab Biosimilar Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Trastuzumab Biosimilar Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Trastuzumab Biosimilar Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Trastuzumab Biosimilar Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Trastuzumab Biosimilar Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Trastuzumab Biosimilar Sales (K Units), 2018-2023
Table 15. By Type - Global Trastuzumab Biosimilar Sales (K Units), 2024-2029
Table 16. By Application – Global Trastuzumab Biosimilar Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Trastuzumab Biosimilar Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Trastuzumab Biosimilar Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Trastuzumab Biosimilar Sales (K Units), 2018-2023
Table 20. By Application - Global Trastuzumab Biosimilar Sales (K Units), 2024-2029
Table 21. By Region – Global Trastuzumab Biosimilar Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Trastuzumab Biosimilar Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Trastuzumab Biosimilar Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Trastuzumab Biosimilar Sales (K Units), 2018-2023
Table 25. By Region - Global Trastuzumab Biosimilar Sales (K Units), 2024-2029
Table 26. By Country - North America Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Trastuzumab Biosimilar Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Trastuzumab Biosimilar Sales, (K Units), 2018-2023
Table 29. By Country - North America Trastuzumab Biosimilar Sales, (K Units), 2024-2029
Table 30. By Country - Europe Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Trastuzumab Biosimilar Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Trastuzumab Biosimilar Sales, (K Units), 2018-2023
Table 33. By Country - Europe Trastuzumab Biosimilar Sales, (K Units), 2024-2029
Table 34. By Region - Asia Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Trastuzumab Biosimilar Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Trastuzumab Biosimilar Sales, (K Units), 2018-2023
Table 37. By Region - Asia Trastuzumab Biosimilar Sales, (K Units), 2024-2029
Table 38. By Country - South America Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Trastuzumab Biosimilar Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Trastuzumab Biosimilar Sales, (K Units), 2018-2023
Table 41. By Country - South America Trastuzumab Biosimilar Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Trastuzumab Biosimilar Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Trastuzumab Biosimilar Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Trastuzumab Biosimilar Sales, (K Units), 2024-2029
Table 46. Amgen Inc. Company Summary
Table 47. Amgen Inc. Trastuzumab Biosimilar Product Offerings
Table 48. Amgen Inc. Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Amgen Inc. Key News & Latest Developments
Table 50. Pfizer Inc Company Summary
Table 51. Pfizer Inc Trastuzumab Biosimilar Product Offerings
Table 52. Pfizer Inc Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Pfizer Inc Key News & Latest Developments
Table 54. Samsung Bioepis Company Summary
Table 55. Samsung Bioepis Trastuzumab Biosimilar Product Offerings
Table 56. Samsung Bioepis Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Samsung Bioepis Key News & Latest Developments
Table 58. Merck & Co. Company Summary
Table 59. Merck & Co. Trastuzumab Biosimilar Product Offerings
Table 60. Merck & Co. Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Merck & Co. Key News & Latest Developments
Table 62. Biocon Limited Company Summary
Table 63. Biocon Limited Trastuzumab Biosimilar Product Offerings
Table 64. Biocon Limited Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Biocon Limited Key News & Latest Developments
Table 66. Teva Pharmaceutical Company Summary
Table 67. Teva Pharmaceutical Trastuzumab Biosimilar Product Offerings
Table 68. Teva Pharmaceutical Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Teva Pharmaceutical Key News & Latest Developments
Table 70. Genentech Company Summary
Table 71. Genentech Trastuzumab Biosimilar Product Offerings
Table 72. Genentech Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Genentech Key News & Latest Developments
Table 74. Mundipharma Company Summary
Table 75. Mundipharma Trastuzumab Biosimilar Product Offerings
Table 76. Mundipharma Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Mundipharma Key News & Latest Developments
Table 78. Celltrion Company Summary
Table 79. Celltrion Trastuzumab Biosimilar Product Offerings
Table 80. Celltrion Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Celltrion Key News & Latest Developments
Table 82. Henlius Company Summary
Table 83. Henlius Trastuzumab Biosimilar Product Offerings
Table 84. Henlius Trastuzumab Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Henlius Key News & Latest Developments
Table 86. Trastuzumab Biosimilar Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Trastuzumab Biosimilar Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Trastuzumab Biosimilar Production by Region, 2018-2023 (K Units)
Table 89. Global Trastuzumab Biosimilar Production by Region, 2024-2029 (K Units)
Table 90. Trastuzumab Biosimilar Market Opportunities & Trends in Global Market
Table 91. Trastuzumab Biosimilar Market Drivers in Global Market
Table 92. Trastuzumab Biosimilar Market Restraints in Global Market
Table 93. Trastuzumab Biosimilar Raw Materials
Table 94. Trastuzumab Biosimilar Raw Materials Suppliers in Global Market
Table 95. Typical Trastuzumab Biosimilar Downstream
Table 96. Trastuzumab Biosimilar Downstream Clients in Global Market
Table 97. Trastuzumab Biosimilar Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Trastuzumab Biosimilar Segment by Type in 2022
Figure 2. Trastuzumab Biosimilar Segment by Application in 2022
Figure 3. Global Trastuzumab Biosimilar Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Trastuzumab Biosimilar Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Trastuzumab Biosimilar Revenue, 2018-2029 (US$, Mn)
Figure 7. Trastuzumab Biosimilar Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Trastuzumab Biosimilar Revenue in 2022
Figure 9. By Type - Global Trastuzumab Biosimilar Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
Figure 11. By Type - Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
Figure 12. By Type - Global Trastuzumab Biosimilar Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Trastuzumab Biosimilar Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
Figure 15. By Application - Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
Figure 16. By Application - Global Trastuzumab Biosimilar Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Trastuzumab Biosimilar Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Trastuzumab Biosimilar Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
Figure 20. By Region - Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
Figure 21. By Country - North America Trastuzumab Biosimilar Revenue Market Share, 2018-2029
Figure 22. By Country - North America Trastuzumab Biosimilar Sales Market Share, 2018-2029
Figure 23. US Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Trastuzumab Biosimilar Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Trastuzumab Biosimilar Sales Market Share, 2018-2029
Figure 28. Germany Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 29. France Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Trastuzumab Biosimilar Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Trastuzumab Biosimilar Sales Market Share, 2018-2029
Figure 37. China Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 41. India Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Trastuzumab Biosimilar Revenue Market Share, 2018-2029
Figure 43. By Country - South America Trastuzumab Biosimilar Sales Market Share, 2018-2029
Figure 44. Brazil Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Trastuzumab Biosimilar Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Trastuzumab Biosimilar Sales Market Share, 2018-2029
Figure 48. Turkey Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Trastuzumab Biosimilar Revenue, (US$, Mn), 2018-2029
Figure 52. Global Trastuzumab Biosimilar Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Trastuzumab Biosimilar by Region, 2022 VS 2029
Figure 54. Trastuzumab Biosimilar Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のトラスツズマブバイオシミラー市場予測2023-2029：アジュバント乳がん、転移性乳がん、転移性胃がん、その他] (コード：MMG23LY8720)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトラスツズマブバイオシミラー市場予測2023-2029：アジュバント乳がん、転移性乳がん、転移性胃がん、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のトラスツズマブ注射市場予測 2023年-2029年
  • 世界の注射用トラスツズマブエムタンシン市場2022年：60mg、100mg、150mg、160mg、その他
  • 世界の皮膚糸状菌症治療市場予測2023-2029：Rx、OTC
  • 世界のトリプタン市場予測2023-2029：経口、注射
  • 世界の肝臓用サプリメント市場予測2023-2029：錠剤、粉末、液体

    • ◆H&Iグローバルリサーチのお客様（例）◆